These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 3892343)
1. Immunogenicity of bovine, porcine and semisynthetic human insulin. Venekamp WJ; van der Hooft JC; Jacobsen L; van Schaik CL Neth J Med; 1985; 28 Suppl 1():57-8. PubMed ID: 3892343 [No Abstract] [Full Text] [Related]
2. Insulin antibodies: reduction in various anti-insulin IgG subclasses with human insulin therapy. Kumar D Horm Metab Res; 1993 Jul; 25(7):360-4. PubMed ID: 8406321 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of insulin of various origins. Reeves WG Neth J Med; 1985; 28 Suppl 1():43-6. PubMed ID: 3892338 [No Abstract] [Full Text] [Related]
4. [Anti-bovine or porcine-insulin antibody]. Kobayashi M; Ishibashi O Nihon Rinsho; 1990 Feb; 48 Suppl():841-3. PubMed ID: 2192166 [No Abstract] [Full Text] [Related]
5. Can insulin antibodies of diabetic patients distinguish human insulin from porcine insulin? Ishibashi O; Kobayashi M; Maegawa H; Watanabe N; Takata Y; Okuno Y; Shigeta Y Horm Metab Res; 1986 Jul; 18(7):470-2. PubMed ID: 2427427 [TBL] [Abstract][Full Text] [Related]
6. The occurrence of human insulin-binding antibodies in diabetes. Kosowicz J; Czekalski S; Fajfrowski T Pol Med J; 1972; 11(3):495-501. PubMed ID: 5065462 [No Abstract] [Full Text] [Related]
7. Comparison of purified bovine and monocomponent porcine insulins. Johnson Z; McDonnell J; Devlin JG Ir Med J; 1984 Dec; 77(12):380-1, 383. PubMed ID: 6394540 [No Abstract] [Full Text] [Related]
8. Experience with biosynthetic human insulin in diabetes. Kruger DF; Whitehouse FW; Kahkonen DM; Partamian JO; Fachnie JD; Goldman J; Leach D Henry Ford Hosp Med J; 1983; 31(2):72-6. PubMed ID: 6355014 [No Abstract] [Full Text] [Related]
9. Circulating insulin antibodies during therapy with highly purified neutrally buffered insulins including desphe insulins. Report of a prospective study with 40 cases. Kühnau J; Rüdiger H; Goetz K Exp Clin Endocrinol; 1984 Apr; 83(2):161-7. PubMed ID: 6373318 [TBL] [Abstract][Full Text] [Related]
10. The immunogenicity of insulin preparations. Chance RE; Root MA; Galloway JA Acta Endocrinol Suppl (Copenh); 1976; 205():185-98. PubMed ID: 793278 [TBL] [Abstract][Full Text] [Related]
11. Insulin-binding antibody and hormone dosage in non-resistant diabetes. Hurn BA; Farrant PC; Young BA; Grahame A Postgrad Med J; 1969 Dec; ():Suppl:819+. PubMed ID: 5393006 [No Abstract] [Full Text] [Related]
13. [Immunologic response to insulin therapy]. Saccarello A; De Micheli A; Boeri D; Maiello M Clin Ter; 1982 Aug; 102(3):293-308. PubMed ID: 6183045 [No Abstract] [Full Text] [Related]
14. Efficacy and immunogenicity of human and monocomponent porcine insulin: a randomized double-blind study in diabetic patients previously treated with insulin. Storms GE; Lutterman JA; van 't Laar A Neth J Med; 1986; 29(10):296-302. PubMed ID: 3540688 [No Abstract] [Full Text] [Related]
15. Binding characteristics and crossreactivity of insulin autoantibodies and insulin antibodies directed to three different insulin molecules. Jaeger C; Winter S; Eckhard M; Hardt P; Brendel MD; Bretzel RG Acta Diabetol; 2008 Sep; 45(3):191-4. PubMed ID: 18493700 [TBL] [Abstract][Full Text] [Related]